1. Structural characteristics and immunomodulatory effects of sulfated polysaccharides derived from marine algae
    Yingying Feng et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
  2. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
    Dhana Sekhar Reddy Bandi et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  3. In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader
    Parvin Yavari et al, 2024, Scientific Reports CrossRef
  4. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
    Komala Ingle et al, 2023, PLOS ONE CrossRef
  5. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients
    Nnenna Elebo et al, 2024, BMC Cancer CrossRef
  6. Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
    Nnenna Elebo et al, 2021, Metabolites CrossRef
  7. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
    Ntombikayise Xelwa et al, 2021, Frontiers in Oncology CrossRef
  8. Acute/chronic exposure to bisphenol A induced immunotoxicity in zebrafish and its potential association with pancreatic cancer risk
    Qiuhui Qian et al, 2023, Aquatic Toxicology CrossRef
  9. Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
    Nnenna Elebo et al, 2023, Frontiers in Genetics CrossRef
  10. A Look at Emerging Therapeutic Targets for Gallbladder Cancer: A Multi-Omics Approach
    Pavan Baichan et al, 2023, Gallbladder Cancer CrossRef